Glucose-regulated protein 94 mediates cancer progression via AKT and eNOS in hepatocellular carcinoma
- PMID: 26493996
- DOI: 10.1007/s13277-015-4254-9
Glucose-regulated protein 94 mediates cancer progression via AKT and eNOS in hepatocellular carcinoma
Abstract
Hepatocellular carcinoma (HCC) is a crucial health issue worldwide. High glucose-regulated protein 94 (GRP94) expression has been observed in different types of cancer, suggesting a link between tumor progression and GRP94 expression. However, the mechanisms underlying the role of GRP94 in HCC progression remain unclear. We used specific small hairpin RNA (shRNA) to manipulate GRP94 expression in HCC cells. Tissue arrays, MTT assays, xCELLigence assays, and in vivo xenograft model were performed to identify clinicopathological correlations and to analyze cell growth. We found that high GRP94 expression reflected a poor response and a lower survival rate. In vitro and in vivo studies showed that silencing GRP94 suppressed cancer progression. Mechanistically, GRP94 knockdown reduced AKT, phospho-AKT, and eNOS levels but did not influence the AMPK pathway. Our results demonstrated that GRP94 is a key molecule in HCC progression that modulates the AKT pathway and eNOS levels. Our findings suggest that GRP94 may be a new prognostic and therapeutic target for HCC.
Keywords: AKT; GRP94; HCC; Proliferation; eNOS.
Similar articles
-
Glucose-regulated protein 94 mediates metastasis by CCT8 and the JNK pathway in hepatocellular carcinoma.Tumour Biol. 2016 Jun;37(6):8219-27. doi: 10.1007/s13277-015-4669-3. Epub 2015 Dec 30. Tumour Biol. 2016. PMID: 26718209
-
Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation.Oncol Rep. 2016 Oct;36(4):2193-9. doi: 10.3892/or.2016.5009. Epub 2016 Aug 9. Oncol Rep. 2016. PMID: 27509921
-
Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.Mol Med Rep. 2015 Jan;11(1):597-602. doi: 10.3892/mmr.2014.2652. Epub 2014 Oct 15. Mol Med Rep. 2015. PMID: 25323956
-
Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.J Hepatol. 2013 Oct;59(4):830-41. doi: 10.1016/j.jhep.2013.04.031. Epub 2013 May 7. J Hepatol. 2013. PMID: 23665184 Review.
-
[EEF1A2 inhibits the p53 function in hepatocellular carcinoma via PI3K/AKT/mTOR-dependent stabilization of MDM4].Pathologe. 2014 Nov;35 Suppl 2:177-84. doi: 10.1007/s00292-014-2007-y. Pathologe. 2014. PMID: 25394965 Review. German.
Cited by
-
Glucose-regulated protein 94 deficiency induces squamous cell metaplasia and suppresses PTEN-null driven endometrial epithelial tumor development.Oncotarget. 2016 Mar 22;7(12):14885-97. doi: 10.18632/oncotarget.7450. Oncotarget. 2016. PMID: 26910913 Free PMC article.
-
Glucose-regulated protein 94 mediates progression and metastasis of esophageal squamous cell carcinoma via mitochondrial function and the NF-kB/COX-2/VEGF axis.Oncotarget. 2018 Jan 10;9(10):9425-9441. doi: 10.18632/oncotarget.24114. eCollection 2018 Feb 6. Oncotarget. 2018. PMID: 29507700 Free PMC article.
-
Grp94 in complexes with IgG is a soluble diagnostic marker of gastrointestinal tumors and displays immune-stimulating activity on peripheral blood immune cells.Oncotarget. 2016 Nov 8;7(45):72923-72940. doi: 10.18632/oncotarget.12141. Oncotarget. 2016. PMID: 27662661 Free PMC article.
-
Hsp90 inhibitors as senolytic drugs to extend healthy aging.Cell Cycle. 2018;17(9):1048-1055. doi: 10.1080/15384101.2018.1475828. Epub 2018 Jul 23. Cell Cycle. 2018. PMID: 29886783 Free PMC article. Review.
-
GRP94 is an IGF-1R chaperone and regulates beta cell death in diabetes.Cell Death Dis. 2024 May 29;15(5):374. doi: 10.1038/s41419-024-06754-y. Cell Death Dis. 2024. PMID: 38811543 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous